News
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Buying $100 In ALNY: If an investor had bought $100 of ALNY stock 10 years ago, it would be worth $385.28 today based on a price of $433.41 for ALNY at the time of writing.
9d
Fintel on MSNOppenheimer Upgrades Alnylam Pharmaceuticals (ALNY)
Fintel reports that on August 4, 2025, Oppenheimer upgraded their outlook for Alnylam Pharmaceuticals (NasdaqGS:ALNY) from ...
2d
Barchart on MSNProfits May Be Just Around the Corner for This Strong-Buy Pharma Stock
Alnylam Pharmaceuticals (ALNY) shows strong price momentum, hitting new all-time highs on Aug. 11. ALNY has a 100% technical “Buy” opinion via Barchart. The company boasts a robust pipeline, recent ...
9d
Fintel on MSNWolfe Research Upgrades Alnylam Pharmaceuticals (ALNY)
Fintel reports that on August 4, 2025, Wolfe Research upgraded their outlook for Alnylam Pharmaceuticals (NasdaqGS:ALNY) from ...
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders will have a reason to smile today, with the analysts ...
Alnylam Pharmaceuticals, Inc. shares soar with strong Q2 results, driven by Amvuttra's stellar U.S. launch for ATTR ...
Good morning, ladies and gentlemen, and welcome to the Alnylam Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, July 31, 2025. I would now like to ...
A stellar launch of rare heart disease med Amvuttra has boosted Alnylam’s market cap above $50 billion. | A stellar launch of ...
Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a loss of $66.3 million in its second quarter.
The better-than-expected launch of a rare heart disease drug pushed Alnylam (Nasdaq: ALNY) past the $50 billion market ...
Alnylam Pharmaceuticals’ new cardiovascular drug is off to a stronger-than-expected launch. The treatment, Amvuttra, brought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results